I

India Glycols Ltd
NSE:INDIAGLYCO

Watchlist Manager
India Glycols Ltd
NSE:INDIAGLYCO
Watchlist
Price: 1 217.15 INR 3.25%
Market Cap: 37.7B INR
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

0
Assets
+0%
Growth Rates:
1 Year
+8%
3 Years
+29%
5 Years
+44%
7 Years
-
10 Years
-
0
Liabilities
+0%
Growth Rates:
1 Year
+8%
3 Years
+31%
5 Years
+20%
7 Years
-
10 Years
-
0
Equity
+0%
Growth Rates:
1 Year
+9%
3 Years
+27%
5 Years
+111%
7 Years
-
10 Years
-

Balance Sheet Decomposition
India Glycols Ltd

55.5B
Assets
34.2B
Liabilities
55.5B
Assets
34.2B
Liabilities
Current Assets 16.5B
Cash & Short-Term Investments 2.1B
Receivables 3.9B
Other Current Assets 10.6B
Non-Current Assets 39B
Long-Term Investments 4B
PP&E 34.9B
Intangibles 14.9m
Other Non-Current Assets 54.5m

Balance Sheet
India Glycols Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Millions
Ones
Thousands
Millions
Billions
Annual
Quarterly
Annual
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
217
64
55
50
270
36
34
70
20
270
Cash
217
64
55
50
270
36
34
70
20
270
Short-Term Investments
2 715
726
662
0
0
0
0
0
0
0
Total Receivables
6 158
5 846
4 892
5 374
5 629
7 690
5 715
7 742
7 483
6 750
Accounts Receivables
4 325
3 636
3 904
3 337
3 220
5 687
3 617
3 987
4 547
3 937
Other Receivables
1 833
2 210
988
2 037
2 409
2 003
2 098
3 755
2 935
2 813
Inventory
4 762
5 157
5 180
4 478
6 470
6 822
6 098
6 930
7 538
11 063
Other Current Assets
1 551
972
527
885
1 483
1 402
1 430
1 330
1 422
1 365
Total Current Assets
15 402
12 765
11 317
10 787
13 853
15 950
13 275
16 072
16 462
19 447
PP&E Net
21 842
22 099
22 011
22 448
23 020
23 901
23 086
25 518
28 321
32 803
PP&E Gross
21 842
22 099
22 011
22 448
23 020
23 901
23 086
25 518
28 321
32 803
Accumulated Depreciation
0
705
1 356
2 068
2 824
3 573
3 495
4 073
4 389
5 385
Intangible Assets
8
2
0
0
1
20
19
17
19
16
Note Receivable
469
587
638
477
454
466
467
498
60
45
Long-Term Investments
283
685
886
469
479
489
489
4 175
3 318
3 417
Other Long-Term Assets
27
57
70
34
37
36
3 856
28
404
440
Total Assets
38 031
N/A
36 195
-5%
34 923
-4%
34 215
-2%
37 843
+11%
40 862
+8%
41 192
+1%
46 307
+12%
48 583
+5%
56 168
+16%
Liabilities
Accounts Payable
2 465
4 806
5 787
7 810
7 434
7 220
5 808
6 416
7 518
10 994
Accrued Liabilities
226
239
262
170
182
249
284
319
172
178
Short-Term Debt
14 176
10 161
8 798
5 785
4 667
4 843
4 829
3 523
3 500
3 476
Current Portion of Long-Term Debt
4 450
244
1 506
832
1 375
940
1 384
1 543
1 971
2 554
Other Current Liabilities
2 646
2 911
2 668
2 056
3 593
6 589
5 029
5 687
5 487
6 545
Total Current Liabilities
23 963
18 360
19 022
16 652
17 249
19 840
17 334
17 487
18 649
23 747
Long-Term Debt
3 957
1 954
647
1 724
3 961
4 210
5 155
5 400
5 651
7 452
Deferred Income Tax
2 232
1 984
2 081
2 526
2 890
3 195
3 574
3 381
3 589
3 984
Minority Interest
0
0
0
0
0
0
0
195
0
0
Other Liabilities
126
6 714
5 648
4 861
4 117
3 278
3 444
2 315
1 679
474
Total Liabilities
30 278
N/A
29 013
-4%
27 399
-6%
25 763
-6%
28 217
+10%
30 524
+8%
29 507
-3%
28 388
-4%
29 569
+4%
35 658
+21%
Equity
Common Stock
310
310
310
310
310
310
310
310
310
310
Retained Earnings
7 048
6 472
6 817
7 738
8 911
9 625
10 942
17 176
18 263
19 757
Additional Paid In Capital
396
396
396
396
396
396
396
396
396
396
Other Equity
0
5
1
8
10
9
38
37
45
47
Total Equity
7 753
N/A
7 182
-7%
7 523
+5%
8 451
+12%
9 626
+14%
10 339
+7%
11 685
+13%
17 919
+53%
19 014
+6%
20 510
+8%
Total Liabilities & Equity
38 031
N/A
36 195
-5%
34 923
-4%
34 215
-2%
37 843
+11%
40 862
+8%
41 192
+1%
46 307
+12%
48 583
+5%
56 168
+16%
Shares Outstanding
Common Shares Outstanding
31
31
31
31
31
31
31
31
31
31

See Also

Summary
INDIAGLYCO intrinsic value, competitors valuation, and company profile.
DCF Valuation
INDIAGLYCO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
INDIAGLYCO stock valuation using valuation multiples.
Wall Street Estimates
INDIAGLYCO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
INDIAGLYCO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 243,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.